Attitudes of health care professionals toward carrier screening for cystic fibrosis. A review of the literature

Journal of Community Genetics

Volumn 5, Issue 1, 2014, Pages 13-29

  Janssens, S ^a   De Paepe, A ^a   Borry, P ^b  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Attitude; Carrier; Genetic; Screening; Testing

Indexed keywords

CONSULTATION; CYSTIC FIBROSIS; FAMILY HISTORY; GENETIC RISK; GENETIC SCREENING; HEALTH CARE ACCESS; HEALTH CARE DISPARITY; HEALTH CARE NEED; HEALTH CARE UTILIZATION; HEALTH PERSONNEL ATTITUDE; HEALTH PROGRAM; HIGH RISK POPULATION; HUMAN; MEDICAL EDUCATION; MOLECULAR GENETICS; PATIENT COUNSELING; PRIORITY JOURNAL; REVIEW;

EID: 84899111307     PISSN: 1868310X     EISSN: 18686001     Source Type: Journal    
DOI: 10.1007/s12687-012-0131-z     Document Type: Review

References (81)

1. ACMG The American College of Medical Genetics (2012) Points to Consider in the Clinical Application of Genomic Sequencing. Policy Statement. Available at: http://www.acmg.net/AM/Template.cfm?Section=Policy-Statements&Template=/ CM/HTMLDisplay.cfm&ContentID=6979
2. ACOG The American College of Obstetricians an Gynecologists (2005) Update on carrier screening for cystic fibrosis. Committee Opinion No. 325. Obstet Gynecol 106:1465-1468
3. ACOG The American College of Obstetricians an Gynecologists (2011) Update on carrier screening for cystic fibrosis. Committee Opinion No. 486. Obstet Gynecol 117:1028-1031
4. Andermann A, Blancquaert I, Beauchamp S, Dery V (2008) Revisiting Wilson and Jungner in the genomic age: a review of screening criteria over the past 40years. Bull World Health Organ 86:317-9 (Pubitemid 351521860)
5. Angastiniotis M, Kyriakidou S, Hadjiminas M (1988) The Cyprus thalassemia control program. Birth Defects Orig Artic Ser 23:417-32
6. Angastiniotis MA, Hadjiminas MG (1981) Prevention of thalassaemia in Cyprus. Lancet 1:369-71
7. Axworthy D, Brock DJ, Bobrow M, Marteau TM (1996) Psychological impact of population-based carrier testing for cystic fibrosis: 3-year follow-up. UK cystic fibrosis follow-up study group. Lancet 347:1443-6 (Pubitemid 26161207)
8. Baars MJ, Henneman L, ten Kate LP (2004) Preconceptional cystic fibrosis carrier screening: opinions of general practitioners, gynecologists, and pediatricians in The Netherlands. Genet Test 8:431-6 (Pubitemid 40083110)
9. Barlow-Stewart K, Burnett L, Proos A, Howell V, Huq F, Lazarus R, Aizenberg H (2003) A genetic screening programme for Tay- Sachs disease and cystic fibrosis for Australian Jewish high school students. J Med Genet 40:e45
10. Bekker H, Denniss G, Modell M, Bobrow M, Marteau T (1994) The impact of population based screening for carriers of cystic fibrosis. J Med Genet 31:364-8 (Pubitemid 24157248)
11. Bekker H, Modell M, Denniss G, Silver A, Mathew C, Bobrow M, Marteau T (1993) Uptake of cystic fibrosis testing in primary care: supply push or demand pull? BMJ 306:1584-6 (Pubitemid 23164904)
12. Bell CJ, Dinwiddie DL, Miller NA, Hateley SL, Ganusova EE, Mudge J, Langley RJ, Zhang L, Lee CC, Schilkey FD, Sheth V, Woodward JE, Peckham HE, Schroth GP, Kim RW, Kingsmore SF (2011) Carrier testing for severe childhood recessive diseases by next-generation sequencing. Sci Transl Med 3:69-82
13. Borry P, Henneman L, Lakeman P, ten Kate LP, Cornel MC, Howard HC (2011) Preconceptional genetic carrier testing and the commercial offer directly-to-consumers. Hum Reprod 26:972-7
14. Boulton M, Cummings C, Williamson R (1996) The views of general practitioners on community carrier screening for cystic fibrosis. Br J Gen Pract 46:299-301 (Pubitemid 26154833)
15. Boulton M, Williamson R (1995) General practice and new genetics: what do general practitioners know about community carrier screening for cystic fibrosis? Public Understand Sci 4:255- 267
16. Bruni T, Mameli M, Pravettoni G, Boniolo G (2012) Cystic fibrosis carrier screening in Veneto (Italy): an ethical analysis. Med Health Care Philos 15:321-8
17. Castellani C, Macek M Jr, Cassiman JJ, Duff A, Massie J, ten Kate LP, Barton D, Cutting G, Dallapiccola B, Dequeker E, Girodon E, Grody W, Highsmith EW, Kaariainen H, Kruip S, Morris M, Pignatti PF, Pypops U, Schwarz M, Soller M, Stuhrman M, Cuppens H (2010) Benchmarks for cystic fibrosis carrier screening: a European consensus document. J Cyst Fibros 9:165-78
18. Childs B, Gordis L, Kaback MM, Kazazian HH Jr (1976) Tay-Sachs screening: social and psychological impact. Am J Hum Genet 28:550-8 (Pubitemid 8008374)
19. Darcy D, Tian L, Taylor J, Schrijver I (2011) Cystic fibrosis carrier screening in obstetric clinical practice: knowledge, practices, and barriers, a decade after publication of screening guidelines. Genet Test Mol Biomarkers 15:517-23
20. Delatycki MB (2008) Population screening for reproductive risk for single gene disorders in Australia: now and the future. Twin Res Hum Genet 11:422-30
21. Denayer L, Welkenhuysen M, Evers-Kiebooms G, Cassiman JJ, Van den Berghe H (1996) The CF carrier status is not associated with a diminished self-concept or increased anxiety: results of psychometric testing after at least 1year. Clin Genet 49:232-6 (Pubitemid 26229593)
22. Faden RR, Tambor ES, Chase GA, Geller G, Hofman KJ, Holtzman NA (1994) Attitudes of physicians and genetics professionals toward cystic fibrosis carrier screening. Am J Med Genet 50:1-11 (Pubitemid 24081390)
23. Frumkin A, Zlotogora J (2008) Genetic screening for reproductive purposes at school: is it a good strategy? Am J Med Genet A 146A:264-9
24. Gason AA, Metcalfe SA, Delatycki MB, Petrou V, Sheffield E, Bankier A, Aitken M (2005) Tay Sachs disease carrier screening in schools: educational alternatives and cheekbrush sampling. Genet Med 7:626-32 (Pubitemid 41753014)
25. Gilani AI, Jadoon AS, Qaiser R, Nasim S, Meraj R, Nasir N, Naqvi FF, Latif Z, Memon MA, Menezes EV, Malik I, Memon MZ, Kazim SF, Ahmad U (2007) Attitudes towards genetic diagnosis in Pakistan: a survey of medical and legal communities and parents of thalassemic children. Community Genet 10:140-6 (Pubitemid 46944289)
26. Giordano PC, Plancke A, Van Meir CA, Janssen CA, Kok PJ, Van Rooijen-Nijdam IH, Tanis BC, van Huisseling JC, Versteegh FG (2006) Carrier diagnostics and prevention of hemoglobinopathies in early pregnancy in The Netherlands: a pilot study. Prenat Diagn 26:719-24 (Pubitemid 44252250)
27. Grody WW, Cutting GR, Klinger KW, Richards CS, Watson MS, Desnick RJ, Subcommittee on Cystic Fibrosis Screening AoGSCAACoMG (2001) Laboratory standards and guidelines for population-based cystic fibrosis carrier screening. Genet Med 3:149-154
28. Hartley NE, Scotcher D, Harris H, Williamson P, Wallace A, Craufurd D, Harris R (1997) The uptake and acceptability to patients of cystic fibrosis carrier testing offered in pregnancy by the GP. J Med Genet 34:459-64 (Pubitemid 27268122)
29. Henneman L, Bramsen I, van der Ploeg HM, Ader HJ, van der Horst HE, Gille JJ, ten Kate LP (2001) Participation in preconceptional carrier couple screening: characteristics, attitudes, and knowledge of both partners. J Med Genet 38:695-703 (Pubitemid 32946792)
30. Henneman L, Bramsen I, van Kempen L, van Acker MB, Pals G, van der Horst HE, Ader HJ, van der Ploeg HM, ten Kate LP (2003) Offering preconceptional cystic fibrosis carrier couple screening in the absence of established preconceptional care services. Community Genet 6:5-13 (Pubitemid 36693833)
31. Henneman L, Poppelaars FA, ten Kate LP (2002) Evaluation of cystic fibrosis carrier screening programs according to genetic screening criteria. Genet Med 4:241-9 (Pubitemid 44698558)
32. Hock KT, Christensen KD, Yashar BM, Roberts JS, Gollust SE, Uhlmann WR (2011) Direct-to-consumer genetic testing: an assessment of genetic counselors' knowledge and beliefs. Genet Med 13:325-32
33. Howard HBP (2008) Direct-to-consumer genetic testing: more questions than benefits? Personalised Medicine 5:317-20
34. Howard HC, Borry P (2012) To ban or not to ban? Clinical geneticists' views on the regulation of direct-to-consumer genetic testing. EMBO Rep 13:791-4
35. Human Genetics Commission (2011) Increasing options, informing choice: A report on preconception genetic testing and screening. Available at: http://www.hgc.gov.uk/Client/document.asp?DocId=315
36. Ioannou L, Massie J, Lewis S, Petrou V, Gason A, Metcalfe S, Aitken MA, Bankier A, Delatycki MB (2010) Evaluation of a multidisease carrier screening programme in Ashkenazi Jewish high schools. Clin Genet 78:21-31
37. Jackson L, Pyeritz RE (2011) Molecular technologies open new clinical genetic vistas. Sci Transl Med 3:22-25
38. Jans SM, de Jonge A, Henneman L, Cornel MC, Lagro-Janssen AL (2012) Attitudes of general practitioners and midwives towards ethnicity-based haemoglobinopathy-carrier screening. Eur J Hum Genet. doi:10.1038/ejhg.2012.72
39. Johnson K, Posner SF, Biermann J, Cordero JF, Atrash HK, Parker CS, Boulet S, Curtis MG, Group CAPCW, Select Panel on Preconception C (2006) Recommendations to improve preconception health and health care-United States. A report of the CDC/ ATSDR Preconception care work group and the select panel on preconception care. MMWR Recomm Rep 55:1-23
40. Khoury MJ, McCabe LL, McCabe ER (2003) Population screening in the age of genomic medicine. N Engl J Med 348:50-8 (Pubitemid 36026347)
41. Kolor K, Liu T, St Pierre J, Khoury MJ (2009) Health care provider and consumer awareness, perceptions, and use of direct-toconsumer personal genomic tests, United States, 2008. Genet Med 11:595
42. Lakeman P, Henneman L, Bezemer PD, Cornel MC, ten Kate LP (2006) Developing and optimizing a decisional instrument using self-reported ancestry for carrier screening in a multi-ethnic society. Genet Med 8:502-9
43. Lakeman P, Plass AM, Henneman L, Bezemer PD, Cornel MC, ten Kate LP (2008) Three-month follow-up of Western and non-Western participants in a study on preconceptional ancestry-based carrier couple screening for cystic fibrosis and hemoglobinopathies in The Netherlands. Genet Med 10:820-30
44. Lakeman P, Plass AM, Henneman L, Bezemer PD, Cornel MC, ten Kate LP (2009) Preconceptional ancestry-based carrier couple screening for cystic fibrosis and haemoglobinopathies: what determines the intention to participate or not and actual participation? Eur J Hum Genet 17:999-1009
45. Levenkron JC, Loader S, Rowley PT (1997) Carrier screening for cystic fibrosis: test acceptance and one year follow-up. Am J Med Genet 73:378-86 (Pubitemid 27514778)
46. Loader S, Caldwell P, Kozyra A, Levenkron JC, Boehm CD, Kazazian HH Jr, Rowley PT (1996) Cystic fibrosis carrier population screening in the primary care setting. Am J Hum Genet 59:234-47 (Pubitemid 26189749)
47. McClaren BJ, Delatycki MB, Collins V, Metcalfe SA, Aitken M (2008) It is not in my world': an exploration of attitudes and influences associated with cystic fibrosis carrier screening. Eur J Hum Genet 16:435-444 (Pubitemid 351420376)
48. McQueen MJ (2002) Some ethical and design challenges of screening programs and screening tests. Clin Chim Acta 315:41-48
49. Mennie M, Campbell H, Liston WA, Brock DJ (1998) Attitudes of general practitioners to screening for cystic fibrosis. J Med Screen 5:11-5 (Pubitemid 28272350)
50. Mennie ME, Compton ME, Gilfillan A, Liston WA, Pullen I, Whyte DA, Brock DJ (1993) Prenatal screening for cystic fibrosis: psychological effects on carriers and their partners. J Med Genet 30:543-8 (Pubitemid 23225178)
51. Metcalfe SA (2012) Carrier screening in preconception consultation in primary care. J Community Genet 3:193-203
52. Mitchell JJ, Capua A, Clow C, Scriver CR (1996) Twenty-year outcome analysis of genetic screening programs for Tay-Sachs and beta-thalassemia disease carriers in high schools. Am J Hum Genet 59:793-8 (Pubitemid 26328074)
53. Modra LJ, Massie RJ, Delatycki MB (2010) Ethical considerations in choosing a model for population-based cystic fibrosis carrier screening. Med J Aust 193:157-60
54. Moher D, Liberati A, Tetzlaff J, Altman DG, Group P (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol 62: 1006-12
55. Morgan MA, Driscoll DA, Mennuti MT, Schulkin J (2004) Practice patterns of obstetrician-gynecologists regarding preconception and prenatal screening for cystic fibrosis. Genet Med 6:450-5 (Pubitemid 39304384)
56. Morgan MA, Driscoll DA, Zinberg S, Schulkin J, Mennuti MT (2005) Impact of self-reported familiarity with guidelines for cystic fibrosis carrier screening. Obstet Gynecol 105:1355-61 (Pubitemid 40734269)
57. Morris JK (2004) Is cascade testing a sensible method of population screening? J Med Screen 11:57-58
58. Morris JK, Law MR, Wald NJ (2004) Is cascade testing a sensible method of screening a population for autosomal recessive disorders? Am J Med Genet A 128A:271-275 (Pubitemid 38849896)
59. Ohata T, Tsuchiya A, Watanabe M, Sumida T, Takada F (2009) Physicians' opinion for 'new' genetic testing in Japan. J Hum Genet 54:203-208
60. Ormond KE, Mills PL, Lester LA, Ross LF (2003) Effect of family history on disclosure patterns of cystic fibrosis carrier status. Am J Med Genet C Semin Med Genet 119C:70-77 (Pubitemid 37064103)
61. Payne Y, Williams M, Cheadle J, Stott NC, Rowlands M, Shickle D, West G, Meredith L, Goodchild M, Harper PS, Clarke A (1997) Carrier screening for cystic fibrosis in primary care: evaluation of a project in South Wales. The South Wales cystic fibrosis carrier screening research team. Clin Genet 51:153-163 (Pubitemid 27168381)
62. Poppelaars FA, Henneman L, Ader HJ, Cornel MC, Hermens RP, van der Wal G, ten Kate LP (2003a) How should preconceptional cystic fibrosis carrier screening be provided? Opinions of potential providers and the target population. Community Genet 6:157-165 (Pubitemid 38916114)
63. Poppelaars FA, van der Wal G, Braspenning JC, Cornel MC, Henneman L, Langendam MW, ten Kate LP (2003b) Possibilities and barriers in the implementation of a preconceptional screening programme for cystic fibrosis carriers: a focus group study. Public Health 117:396-403 (Pubitemid 37321767)
64. Poppelaars FA, Ader HJ, Cornel MC, Henneman L, Hermens RP, van der Wal G, ten Kate LP (2004) Attitudes of potential providers towards preconceptional cystic fibrosis carrier screening. J Genet Couns 13:31-44 (Pubitemid 39024182)
65. Powell KP, Cogswell WA, Christianson CA, Dave G, Verma A, Eubanks S, Henrich VC (2012) Primary care physicians' awareness, experience and opinions of direct-to-consumer genetic testing. J Genet Couns 21:113-126
66. Qureshi N, Armstrong S, Modell B (2006) GPs' opinions of their role in prenatal genetic services: a cross-sectional survey. Fam Pract 23:106-110
67. Radhakrishnan M, van Gool K, Hall J, Delatycki M, Massie J (2008) Economic evaluation of cystic fibrosis screening: a review of the literature. Health Policy 85:133-147 (Pubitemid 350297485)
68. Raeburn JA (1994) Screening for carriers of cystic fibrosis. Screening before pregnancy is needed. BMJ 309:1428-1429
69. Ready K, Haque IS, Srinivasan BS, Marshall JR (2012) Knowledge and attitudes regarding expanded genetic carrier screening among women's healthcare providers. Fertil Steril 97:407-413
70. Riskin-Mashiah S, Auslander R (2007) Preconception care-when and what: the attitude of Israeli gynaecologists to preconception counseling. Arch Gynecol Obstet 275:367-371 (Pubitemid 46466377)
71. Roberts T, Schwarz MJ, Kerr-Liddell R, Hinks JL, Super M (2003) Cascade carrier-testing in cystic fibrosis. Paediatr Respir Rev 4:293-298 (Pubitemid 37493332)
72. Rommens JM, Iannuzzi MC, Kerem B, Drumm ML, Melmer G, Dean M, Rozmahel R, Cole JL, Kennedy D, Hidaka N et al (1989) Identification of the cystic fibrosis gene: chromosome walking and jumping. Science 245:1059-1065 (Pubitemid 19231813)
73. Ross LF (2006) Heterozygote carrier testing in high schools abroad: what are the lessons for the U.S.? J Law Med Ethics 34:753-764
74. Rowley PT, Loader S, Levenkron JC, Phelps CE (1993) Cystic fibrosis carrier screening: knowledge and attitudes of prenatal care providers. Am J Prev Med 9:261-266 (Pubitemid 23320064)
75. Shickle D, May A (1989) Knowledge and perceptions of haemoglobinopathy carrier screening among general practitioners in Cardiff. J Med Genet 26:109-112 (Pubitemid 19047361)
76. Watson EK, Marchant J, Bush A, Williamson B (1992) Attitudes towards prenatal diagnosis and carrier screening for cystic fibrosis among the parents of patients in a paediatric cystic fibrosis clinic. J Med Genet 29:490-491
77. Watson EK, Williamson R, Chapple J (1991) Attitudes to carrier screening for cystic fibrosis: a survey of health care professionals, relatives of sufferers and other members of the public. Br J Gen Pract 41:237-240
78. Weinreich SS, de Lange-de Klerk ES, Rijmen F, Cornel MC, de Kinderen M, Plass AM (2009) Raising awareness of carrier testing for hereditary haemoglobinopathies in high-risk ethnic groups in The Netherlands: a pilot study among the general public and primary care providers. BMC Publ Health 9:338. doi:10.1186/1471-2458-9-338
79. Verweij M (2008) Preconceptional CF screening and the problem of medicalisation. In: Lakeman P (ed) Preconceptional carrier couple screening for cystic fibrosis and hemoglobinopathies, An ancestry-based offer in a multi-ethnic society. Gildeprint drukkerijen en B.V., Enschede, Amsterdam, pp 265-271
80. Wilson JMG, Jungner G (1968) Principles and practice of screening for disease. Geneva: World Health Organisation. Public Health Papers No.34 (No.34). Available at: http://apps.who.int/iris/bitstream/10665/37650/1/WHOPHP34.pdf
81. Witt DR, Schaefer C, Hallam P, Wi S, Blumberg B, Fishbach A, Holtzman J, Kornfeld S, Lee R, Nemzer L, Palmer R (1996) Cystic fibrosis heterozygote screening in 5,161 pregnant women. Am J Hum Genet 58:823-35 (Pubitemid 26086674)